131220 — Daihan Scientific Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual income statement for Daihan Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	55,165	61,508	66,281	72,280	73,702
Cost of Revenue
Gross Profit	13,993	15,458	18,449	21,564	22,170
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	52,965	58,528	60,416	65,055	67,535
Operating Profit	2,200	2,980	5,865	7,224	6,167
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,393	3,076	6,102	7,514	6,424
Provision for Income Taxes
Net Income After Taxes	1,950	2,752	5,015	6,242	5,222
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,227	1,709	3,767	4,702	3,845
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,227	1,709	3,767	4,702	3,845
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	164	312	528	661	542
Dividends per Share